EUVIMEDEUVIMED entdecken
LeserbriefOpen Access

First-Line Tislelizumab Combined with Bevacizumab and CAPOX for Metastatic Gastroesophageal Adenocarcinoma with Low Programmed Death-Ligand 1 Expression

Ru Jia, Yan-Rong Wang, Fang-Fang Liu, Yue Ma, Hai-Yan Si, Lu Han, Miao-Miao Gou, Zhao-Li Tan, Nan Zhang, Guo-Chao Deng, Meng-Jiao Fan, Yue Shi und 7 weitere

Cancer Communications · 01.01.2026 · 46

DOI: 10.34133/cancomm.0024 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Cancer Communications, online erschienen am 16.04.2026. Verfasst von Ru Jia und 18 weiteren Autor:innen. Beteiligte Einrichtung: Senior Department of Oncology, Chinese PLA General Hospital, Beijing, P. R. China. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Senior Department of Oncology, Chinese PLA General Hospital, Beijing, P. R. China.
  • Senior Department of Oncology, Medical School of Chinese PLA, Beijing, P. R. China.
  • Kanghui Medicine, Kanghui Biotechnology Co., Ltd., Shenyang, Liaoning, P. R. China.

Zitieren

APA

Jia, R., Wang, Y. R., Liu, F. F., Ma, Y., Si, H. Y., Han, L., Gou, M. M., Tan, Z. L., Zhang, N., Deng, G. C., Fan, M. J., Shi, Y., Zhang, Y. Y., Jia, Y. S., Xu, J. N., Su, X. X., Han, Q. L., Wang, Z. K., & Dai, G. H. (2026). First-Line Tislelizumab Combined with Bevacizumab and CAPOX for Metastatic Gastroesophageal Adenocarcinoma with Low Programmed Death-Ligand 1 Expression. Cancer Communications, 46. https://doi.org/10.34133/cancomm.0024

Vancouver

Jia R, Wang YR, Liu FF, Ma Y, Si HY, Han L, et al. First-Line Tislelizumab Combined with Bevacizumab and CAPOX for Metastatic Gastroesophageal Adenocarcinoma with Low Programmed Death-Ligand 1 Expression. Cancer Communications. 2026;46. doi:10.34133/cancomm.0024

BibTeX
@article{Jia2026,
  author = {Jia, Ru and Wang, Yan-Rong and Liu, Fang-Fang and Ma, Yue and Si, Hai-Yan and Han, Lu and Gou, Miao-Miao and Tan, Zhao-Li and Zhang, Nan and Deng, Guo-Chao and Fan, Meng-Jiao and Shi, Yue and Zhang, Yao-Yue and Jia, Yu-Shan and Xu, Jun-Nan and Su, Xiao-Xing and Han, Quan-Li and Wang, Zhi-Kuan and Dai, Guang-Hai},
  title = {First-Line Tislelizumab Combined with Bevacizumab and CAPOX for Metastatic Gastroesophageal Adenocarcinoma with Low Programmed Death-Ligand 1 Expression},
  journal = {Cancer Communications},
  year = {2026},
  volume = {46},
  doi = {10.34133/cancomm.0024}
}
Kostenlos starten →